Home › Retrophin Signs U.S. License Agreement for Syntocinon Nasal Spray (Oxytocin)
 

Keywords :   


Retrophin Signs U.S. License Agreement for Syntocinon Nasal Spray (Oxytocin)

2013-12-19 08:09:31| dairynetwork News Articles

Retrophin, Inc. recently announced that it has signed an agreement with Novartis Pharma AG for an exclusive U.S. license for Syntocinon™ Nasal Spray, the intranasal formulation of a synthetic version of the naturally occurring peptide hormone oxytocin, for an upfront payment of $5.0 million plus milestone payments and royalties. Syntocinon™ Nasal Spray was approved in the U.S. in 1960 to assist initial postpartum milk ejection, but was discontinued by Novartis in 1997 for

Tags: agreement license signs spray

Category:Agriculture and Forestry

Latest from this category

All news
22.11Carcass management workshop gets pork producers FAD prepared
22.11Are we close to eliminating Mycoplasma hyopneumoniae from the U.S. swine herd?
22.11Farm Progress America, Nov. 22, 2024
22.11Farm Progress America, Nov. 22, 2024
21.11Pasture and range mostly in poor condition
21.11Tallow seeing renewed interest as sustainable fat
21.11Managing seasonal variation, herd constraints in a hog operation
21.11Dominican Republic signs swine biosecurity protocol with international organizations
Agriculture and Forestry »
22.11ONE PIECE 1109
22.1190old
22.11SHIMANO
22.11Hi-STANDARD growing up
22.1111th ANNIVERSARY SPECIAL SET
22.11 3
22.11
22.11MSR LIGHTNING ASCENT25
More »